Mario Galgani Selected Research

HMGA1b Protein

1/2019

Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Galgani Research Topics

Disease

8	Neoplasms (Cancer) 07/2021 - 06/2010
7	Inflammation (Inflammations) 01/2021 - 01/2010
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 07/2013
6	Obesity 01/2017 - 01/2010
4	Multiple Sclerosis 10/2019 - 12/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 11/2015
2	COVID-19 01/2021 - 01/2021
2	Starvation 01/2021 - 09/2012
2	Infections 01/2021 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2019
2	Neuroblastoma 12/2016 - 10/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 10/2013
2	Insulin Resistance 10/2013 - 05/2011
2	Breast Neoplasms (Breast Cancer) 07/2010 - 06/2010
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2021
1	Idiopathic Pulmonary Fibrosis 07/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Granuloma 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020
1	Ketosis 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Glycogen Storage Disease (Glycogenosis) 01/2017
1	Relapsing-Remitting Multiple Sclerosis 09/2015
1	Melanoma (Melanoma, Malignant) 12/2014
1	Disease Progression 07/2013
1	Fibrosarcoma 03/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2010
1	Non-alcoholic Fatty Liver Disease 06/2010
1	Fatty Liver 06/2010
1	Fibrosis (Cirrhosis) 06/2010
1	Carcinogenesis 06/2010

Drug/Important Bio-Agent (IBA)

8	LeptinIBA 01/2019 - 06/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
4	AdipokinesIBA 01/2019 - 06/2010
3	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2019
3	Leptin ReceptorsIBA 09/2015 - 06/2010
2	OsteoprotegerinIBA 12/2020 - 09/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020 - 09/2015
2	Peroxidase (Myeloperoxidase)IBA 12/2020 - 09/2015
2	CD40 Ligand (CD40L)IBA 12/2020 - 09/2015
2	C-PeptideIBA 12/2020 - 01/2020
2	Hormones (Hormone)IBA 01/2017 - 12/2010
2	Peptides (Polypeptides)IBA 12/2010 - 06/2010
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 07/2021
1	DNA (Deoxyribonucleic Acid)IBA 07/2021
1	AntigensIBA 01/2021
1	CholesterolIBA 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	LipidsIBA 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	ResistinIBA 12/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Annexin A1IBA 10/2019
1	GlucocorticoidsIBA 10/2019
1	HMGA1b ProteinIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Glucose-6-PhosphateIBA 01/2017
1	GlycogenIBA 01/2017
1	Thimerosal (Thiomersal)IBA 12/2016
1	Interleukin-2 (IL2)IBA 11/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2015
1	Glatiramer Acetate (Copaxone)FDA Link 09/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	Caspase 3 (Caspase-3)IBA 10/2014
1	Diethylhexyl Phthalate (DEHP)IBA 10/2014
1	Ubiquitin-Conjugating EnzymesIBA 03/2013
1	UbiquitinIBA 03/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2013
1	Pharmaceutical PreparationsIBA 03/2012
1	MethylcholanthreneIBA 03/2012
1	RimonabantIBA 03/2012
1	Glycoproteins (Glycoprotein)IBA 12/2010
1	ErbB Receptors (EGF Receptor)IBA 12/2010
1	Trastuzumab (Herceptin)FDA Link 07/2010
1	formestaneIBA 07/2010
1	Estrogen Receptor alphaIBA 06/2010
1	Interleukin-17 (Interleukin 17)IBA 01/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 07/2010
1	Caloric Restriction 01/2021
1	Immunotherapy 01/2021
1	Glycemic Control 01/2020
1	Drug Therapy (Chemotherapy) 01/2020